Terms: = Kidney tumors AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Diagnosis
6 results:
1. [Cytopathological characteristics of smarca4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
2. Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors.
Vejmelkova K; Pokorna P; Noskova K; Faustmannova A; Drabova K; Pavelka Z; Bajciova V; Broz M; Tinka P; Jezova M; Palova H; Kren L; Valik D; Slaby O; Sterba J
Sci Rep; 2023 Dec; 13(1):21623. PubMed ID: 38062114
[TBL] [Abstract] [Full Text] [Related]
3.
Chetty R; Serra S
J Clin Pathol; 2020 May; 73(5):257-260. PubMed ID: 32312722
[TBL] [Abstract] [Full Text] [Related]
4. [Pathological and molecular features of malignancies underlined by BAF complexes inactivation].
Le Quang M; Ranchère-Vince D; Le Loarer F
Ann Pathol; 2019 Dec; 39(6):399-413. PubMed ID: 31255411
[TBL] [Abstract] [Full Text] [Related]
5. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L
Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006
[TBL] [Abstract] [Full Text] [Related]
6. Rhabdoid tumor predisposition syndrome.
Sredni ST; Tomita T
Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
[TBL] [Abstract] [Full Text] [Related]